ACUTE LYMPHOBLASTIC LEUKEMIAS: BIOMARKERS, MOLECULAR MARKERS, AND MINIMAL RESIDUAL DISEASE IN DIAGNOSIS AND PROGNOSIS

被引：0

作者：

Xu, Jason ^{[1
,2
]}

Sussman, Jonathan ^{[1
]}

Yang, Austin ^{[3
,4
]}

Yoshimura, Satoshi ^{[5
]}

Chen, Changya ^{[2
]}

Elghawy, Omar ^{[6
]}

Vincent, Tiffaney ^{[7
]}

Diorio, Caroline ^{[2
]}

Bandyopadyay, Shovik ^{[3
,4
]}

Hu, Jianzhong ^{[8
]}

Li, Alexander Lai ^{[7
]}

Chen, Gregory M. ^{[9
]}

Chen, Chia-Hui ^{[7
]}

Shraim, Rawan ^{[2
]}

Newman, Haley ^{[2
]}

Ding, Yang ^{[7
]}

Li, Elizabeth ^{[7
]}

Yu, Wenbao

Thadi, Anusha ^{[7
]}

Ahn, Kyung Jin ^{[3
,4
]}

Polonen, Petri ^{[10
]}

Elsayed, Abdelrahman ^{[8
]}

Frank, David ^{[11
]}

Raetz, Elizabeth A. ^{[12
]}

Loh, Mignon L. ^{[13
]}

Wood, Brent L. ^{[14
]}

Winter, Stuart S. ^{[15
]}

Dunsmore, Kimberly P. ^{[16
]}

Devidas, Meenakshi ^{[8
]}

Qu, Chunxu ^{[10
]}

Pounds, Stanley ^{[17
]}

Hunger, Stephen P. ^{[18
]}

Mullighan, Charles G. ^{[10
]}

Yang, Jun J. ^{[5
]}

Tan, Kai ^{[19
]}

Teachey, David T. ^{[20
]}

机构：

[1] Perelman Sch Med, Philadelphia, PA USA

[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[4] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA USA

[5] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA

[6] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA USA

[7] Childrens Hosp Philadelphia, Philadelphia, PA USA

[8] St Jude Childrens Res Hosp, Memphis, TN USA

[9] Univ Penn Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[10] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA

[11] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA USA

[12] Dept Pediat, NYU Langone Hlth, New York, NY USA

[13] Univ Washington, Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Fred Hutch Canc Ctr, Seattle, WA USA

[14] Childrens Hosp Angeles, Dept Pathol, Lab Med, Los Angeles, CA USA

[15] Canc & Blood Disorders, Childrens Minnesota, Eagan, MN USA

[16] Univ Virginia Hlth Sci Ctr, Charlottesville, VA USA

[17] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN USA

[18] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[19] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA

[20] Childrens Hosp Philadelphia, Div Oncol, Rutledge, PA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-211090

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

614

引用

页码：1464 / 1465

页数：2

共 50 条

[21] Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
Della Starza, Irene
De Novi, Lucia Anna
Elia, Loredana
Bellomarino, Vittorio
Beldinanzi, Marco
Soscia, Roberta
Cardinali, Deborah
Chiaretti, Sabina
Guarini, Anna
Foa, Robin
CANCERS, 2023, 15 (02)
[22] Minimal residual disease in children with acute lymphoblastic leukaemia
Catovsky, D
Farahat, N
Matutes, E
Powles, RL
Pinkerton, CR
LANCET, 1998, 351 (9111): : 1287 - 1287
[23] Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
Kruse, Aaron
Abdel-Azim, Nour
Kim, Hye Na
Ruan, Yongsheng
Phan, Valerie
Ogana, Heather
Wang, William
Lee, Rachel
Gang, Eun Ji
Khazal, Sajad
Kim, Yong-Mi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
[24] Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia
Yu, Chih-Hsiang
Jou, Shiann-Tarng
Su, Ying-Hui
Coustan-Smith, Elane
Wu, Gang
Cheng, Chao-Neng
Lu, Meng-Yao
Lin, Kai-Hsin
Wu, Kang-Hsi
Chen, Shu-Huey
Huang, Fang-Liang
Chang, Hsiu-Hao
Wang, Jinn-Li
Yen, Hsiu-Ju
Li, Meng-Ju
Chou, Shu-Wei
Ho, Wan-Ling
Liu, Yen-Lin
Chang, Chia-Ching
Lin, Ze-Shiang
Lin, Chien-Yu
Chen, Hsuan-Yu
Ni, Yu-Ling
Lin, Dong-Tsamn
Lin, Shu-Wha
Yang, Jun J.
Ni, Yen-Hsuan
Pui, Ching-Hon
Yu, Sung-Liang
Yang, Yung-Li
CANCER, 2023, 129 (05) : 790 - 802
[25] GENE REARRANGEMENTS AS MARKERS OF CLONAL VARIATION AND MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
WRIGHT, JJ
POPLACK, DG
BAKHSHI, A
REAMAN, G
COLE, D
JENSEN, JP
KORSMEYER, SJ
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 735 - 741
[26] Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia
Radich, JP
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 91 - 103
[27] Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis
Foroni, L
Harrison, CJ
Hoffbrand, AV
Potter, MN
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (01) : 7 - 24
[28] New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD).
Goekbuget, Nicola
Brueggemann, Monika
Arnold, Renate
Bartram, Claus-Rainer
Fietkau, Rainer
Freund, Mathias
Ganser, Arnold
Kneba, Michael
Lipp, Thomas
Ludwig, Wolf-Dieter
Maschmeyer, Georg
Messerer, Dorle
Raff, Thorsten
Rieder, Harald
Thiel, Eckhard
Hoelzer, Dieter
BLOOD, 2009, 114 (22) : 42 - 42
[29] POOR-PROGNOSIS ACUTE LYMPHOBLASTIC LEUKEMIAS
WEIL, M
JACQUILLAT, C
AUCLERC, MF
SCHAISON, G
CHASTANG, C
BERNARD, J
RECENT RESULTS IN CANCER RESEARCH, 1982, 80 : 36 - 41
[30] Detection of minimal residual disease in acute leukemias by flow cytometry.
Scolnik, MP
MEDICINA-BUENOS AIRES, 2000, 60 : 83 - 86

← 1 2 3 4 5 →